// App-Quantinova.ai

AB0310 : TROUGH CONCENTRATION AND ESTIMATED CLEARANCE CAN DETECT IMMUNOGENICITY TO ADALIMUMAB IN RA PATIENTS: A PROSPECTIVE LONGITUDINAL MULTICENTRE STUDY

Researchers

Presenter

  • D. Ternant

Principal Investigators

  • N. Szely

  • S. Hacein-Bey

  • A. Gleizes

  • C. Richez

  • J. Manson

  • M. Soubrier

  • O. Brocq

  • J. Avouac

  • A. Fogdell-Hahn

  • P. Dnnes

  • G. Paintaud

  • C. Desvignes

  • F. Deisenhammer

  • S. Spindeldreher

  • M. Pallardy

  • X. Mariette

  • D. Mulleman

Medical Centers

  • Pharmacologie-Toxicologie, Tours, France

  • University of Tours, EA7501 GICC, Tours, France

  • Université de Paris Saclay, INSERM, U1185, Le Kremlin-Bicêtre, France

  • Paris-Saclay University Hospital, Immunology, Le Kremlin Bicêtre, France

  • CHU Bordeaux Dermatology, Bordeaux, France

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Clermont-Ferrand, Rheumatology, Clermont-Ferrand, France

  • Centre Hospitalier Princesse Grace, Rheumatology, Monaco, Monaco

  • Hôpital Cochin, AP-HP, Rheumatology, Paris, France

  • Karolinska Institutet, Clinical Neuroscience, Stockholm, Sweden

  • SciCross AB, Skövde, Sweden

  • Innsbruck Medical University, Innsbruck, Austria

  • Novartis Institutes for Biomedical Research, Drug Metabolism Pharmacokinetics-Biologics, Basel, Switzerland

  • UniverSud, Paris-Saclay, INSERM UMR-S , Chatenay-Malabry, France

  • Université Paris-Saclay, INSERM, UMR1184, Rheumatology, Le Kremlin Bicêtre, France

  • University of Tours, EA 7501, Rheumatology, Tours, France

Locations

  • France

  • United Kingdom

  • Monaco

  • Sweden

  • Austria

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Biogen and IDEC Corporation and Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved